李珊;黄慧;徐作军;
LI Shan;HUANG Hui;XU Zuo-jun;Department of Respiratory Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院呼吸内科

摘要(Abstract)：

特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)是一种慢性进展性致纤维化性疾病,预后极差。IPF以中老年男性多见,容易出现多种临床合并症,包括肺气肿、肺癌、心血管疾病等。存在合并症的IPF患者临床症状更多、预后更差。本文详细阐述影响特发性肺纤维化治疗和预后的常见合并症,以期提高临床对于IPF合并症的认识和诊疗水平,从而改善IPF患者的生活质量及预后。
Idiopathic pulmonary fibrosis( IPF) is a progressive fatal disease of the lung with unknown etiology and limited treatment options. It is more common in men and the elderly aged over 50 years,which also have a high incidence of emphysema,lung neoplasms,and cardiovascular disease. IPF patients with comorbidities often have a worse prognosis than those with IPF alone. We write this article in reference to common comorbidities in patients with idiopathic pulmonary fibrosis to draw physicians' attention. Clinical physicians should know that much can be done to identify and alleviate symptoms of those comorbidities,and to potentially improve the overall quality of life of these patients.

关键词(KeyWords)： 特发性肺纤维化;合并症;肺动脉高压;肺气肿;肺癌
idiopathic pulmonary fibrosis;comorbidity;pulmonary hypertension;emphysema;lung neoplasms

Abstract:

Keywords:

基金项目(Foundation): 北京市自然科学基金项目(7162157)

作者(Authors): 李珊;黄慧;徐作军;
LI Shan;HUANG Hui;XU Zuo-jun;Department of Respiratory Medicine,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

参考文献(References)：

• [1]Karampitsakos T,Tzilas V,Tringidou R,et al.Lung cancer in patients with idiopathic pulmonary fibrosis[J].Pulm Pharmacol Ther,2017,45:1-10.
• [2]Tomassetti S,Gurioli C,Ryu JH,et al.The impact of lung cancer on survival of idiopathic pulmonary fibrosis[J].Chest,2015,147:157-164.
• [3]Watanabe A,Higami T,Ohori S,et al.Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?[J].J Thorac Cardiovasc Surg,2008,136:1357-1363.
• [4]Ono T,Hareyama M,Nakamura T,et al.The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis:a single center experience[J].Radiat Oncol,2016,11:56.
• [5]Iwata T,Yoshida S,Nagato K,et al.Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis[J].Surg Today,2015,45:1263-1270.
• [6]Mediavilla-Varela M,Boateng K,Noyes D,et al.The antifibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts[J].BMC Cancer,2016,16:176.
• [7]Reck M,Kaiser R,Mellemgaard A,et al.Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer(LUME-Lung 1):a phase 3,double-blind,randomised controlled trial[J].Lancet Oncol,2014,15:143-155.
• [8]Cottin V,Nunes H,Brillet PY,et al.Combined pulmonary fibrosis and emphysema:a distinct underrecognised entity[J].Eur Respir J,2005,26:586-593.
• [9]Cottin V,Hansell DM,Sverzellati N,et al.Effect of emphysema extent on serial lung function in patients with idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2017,196:1162-1171.
• [10]Sugino K,Ishida F,Kikuchi N,et al.Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone[J].Respirology,2014,19:239-245.
• [11]Kohashi Y,Arai T,Sugimoto C,et al.Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy[J].Respiration,2016,92:220-228.
• [12]Mejia M,Carrillo G,Rojas-Serrano J,et al.Idiopathic pulmonary fibrosis and emphysema:decreased survival associated with severe pulmonary arterial hypertension[J].Chest,2009,136:10-15.
• [13]Dong F,Zhang Y,Chi F,et al.Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema[J].Int J Clin Exp Med,2015,8:8617-8625.
• [14]Raghu G,Amatto VC,Behr J,et al.Comorbidities in idiopathic pulmonary fibrosis patients:a systematic literature review[J].Eur Respir J,2015,46:1113-1130.
• [15]Hayes D,Jr.,Black SM,Tobias JD,et al.Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation[J].Ann Thorac Surg,2016,101:246-252.
• [16]Alkukhun L,Wang XF,Ahmed MK,et al.Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis[J].Respir Med,2016,117:65-72.
• [17]Idiopathic Pulmonary Fibrosis Clinical Research N,Zisman DA,Schwarz M,et al.A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis[J].N Engl J Med,2010,363:620-628.
• [18]Han MK,Bach DS,Hagan PG,et al.Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction[J].Chest,2013,143:1699-1708.
• [19]Mermigkis C,Bouloukaki I,Antoniou K,et al.Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis[J].Sleep Breath,2015,19:385-391.
• [20]Gille T,Didier M,Boubaya M,et al.Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis[J].Eur Respir J,2017,49:1601934.
• [21]Raghu G,Collard HR,Egan JJ,et al.An official ATS/ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management[J].Am J Respir Crit Care Med,2011,183:788-824.
• [22]Raghu G,Freudenberger TD,Yang S,et al.High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis[J].Eur Respir J,2006,27:136-142.
• [23]Lee JS,Song JW,Wolters PJ,et al.Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis[J].Eur Respir J,2012,39:352-358.
• [24]Lee JS.The Role of Gastroesophageal Reflux and Microaspiration in Idiopathic Pulmonary Fibrosis[J].Clin Pulm Med,2014,21:81-85.
• [25]Lee JS,Collard HR,Anstrom KJ,et al.Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis:an analysis of data from three randomised controlled trials[J].Lancet Respir Med,2013,1:369-376.
• [26]Linden PA,Gilbert RJ,Yeap BY,et al.Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation[J].J Thorac Cardiovasc Surg,2006,131:438-446.
• [27]Fulton BG,Ryerson CJ.Managing comorbidities in idiopathic pulmonary fibrosis[J].Int J Gen Med,2015,8:309-318.
• [28]Sprunger DB,Olson AL,Huie TJ,et al.Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease[J].Eur Respir J,2012,39:125-132.
• [29]Dalleywater W,Powell HA,Fogarty AW,et al.Venous thromboembolism in people with idiopathic pulmonary fibr-osis:a population-based study[J].Eur Respir J,2014,44:1714-1715.
• [30]Nathan SD,Barnett SD,Urban BA,et al.Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients[J].Chest,2003,123:1758-1763.
• [31]Noth I,Anstrom KJ,Calvert SB,et al.A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2012,186:88-95.
• [32]Rochwerg B,Raghu G.Reply:Can Warfarin Be Used in the Treatment of Pulmonary Embolism in Idiopathic Pulmonary Fibrosis?[J].Am J Respir Crit Care Med,2016,193:811.
• [33]Hubbard RB,Smith C,Le Jeune I,et al.The association between idiopathic pulmonary fibrosis and vascular disease:a population-based study[J].Am J Respir Crit Care Med,2008,178:1257-1261.
• [34]Kim WY,Mok Y,Kim GW,et al.Association between idiopathic pulmonary fibrosis and coronary artery disease:a casecontrol study and cohort analysis[J].Sarcoidosis Vasc Diffuse Lung Dis,2015,31:289-296.
• [35]Nathan SD,Basavaraj A,Reichner C,et al.Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis[J].Respir Med,2010,104:1035-1041.
• [36]Nathan SD,Weir N,Shlobin OA,et al.The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic pulmonary fibrosis[J].Respirology,2011,16:481-486.
• [37]Nielsen TD,Bahnson T,Davis RD,et al.Atrial fibrillation after pulmonary transplant[J].Chest,2004,126:496-500.
• [38]Gribbin J,Hubbard R,Smith C.Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis[J].Respir Med,2009,103:927-931.
• [39]Enomoto T,Usuki J,Azuma A,et al.Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis[J].Chest,2003,123:2007-2011.
• [40]Kim YJ,Park JW,Kyung SY,et al.Clinical characteristics of idiopathic pulmonary fibrosis patients with diabetes mellitus:the national survey in Korea from 2003 to 2007[J].J Korean Med Sci,2012,27:756-760.